Intervention Delivery Matters: What Mothers at High Risk for Type 2 Diabetes Want in a Diabetes Prevention Program-Results from a Comparative Effectiveness Trial

Kelly N B Palmer; Valene E Garr Barry; David G Marrero; Brett M McKinney; Anne N Graves; Chelsy K Winters; Tamara S Hannon

doi:10.1007/s13300-020-00891-1

Intervention Delivery Matters: What Mothers at High Risk for Type 2 Diabetes Want in a Diabetes Prevention Program-Results from a Comparative Effectiveness Trial

Diabetes Ther. 2020 Oct;11(10):2411-2418. doi: 10.1007/s13300-020-00891-1. Epub 2020 Aug 8.

Authors

Kelly N B Palmer¹, Valene E Garr Barry², David G Marrero³, Brett M McKinney³, Anne N Graves⁴, Chelsy K Winters⁴, Tamara S Hannon⁵

Affiliations

¹ Department of Medicine, Indiana University School of Medicine, Indianapolis, USA. kpalmer1@arizona.edu.
² Department of Nutrition Sciences, University of Alabama, Birmingham, AL, USA.
³ Department of Medicine, Indiana University School of Medicine, Indianapolis, USA.
⁴ YMCA of Greater Indianapolis, Indianapolis, USA.
⁵ Department of Pediatrics, Indiana University School of Medicine, Indianapolis, USA.

Abstract

Participants in the ENCOURAGE Healthy Families Study, a family-focused, modified Diabetes Prevention Program, reported challenges to and preferences for engaging in a diabetes prevention program. Challenges with flexible intervention delivery, accessibility, the traditional group-based format, and Coronavirus Disease 2019 (COVID-19) exposure risk can be mitigated by participant preferences for one-on-one, virtual/online intervention delivery.Trial Registration: ClinicalTrials.gov identifier, NCT01823367.

Keywords: COVID-19; Gestational diabetes; Lifestyle intervention; Prediabetes; Primary prevention; Type 2 diabetes.

Associated data

ClinicalTrials.gov/NCT01823367

Abstract

Associated data

Grants and funding